Targeting endothelial cytoskeletal remodeling to restore angiogenesis in ischemic heart disease
Biomed Pharmacother. 2026 Jun 11;201:119650. doi: 10.1016/j.biopha.2026.119650. Online ahead of print.ABSTRACTIschemic heart disease (IHD) remains a leading cause of morbidity and mortality worldwide. Effective restoration of myocardial perfusion relies on angiogenesis, a process frequently impaired

